NCT02209701View on ClinicalTrials.gov

Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

July 31, 2000

Conditions
Head and Neck Neoplasms
Interventions
DRUG

Porfiromycin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02209701 - Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors | Biotech Hunter | Biotech Hunter